These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 23404201)
1. Use of a computerized order set to increase prescription of calcium and vitamin D supplementation in patients receiving glucocorticoids. Kohler MJ; Amezaga M; Drozd J; Crowley ST; Gulanski B; Anderson DR; Fraenkel L J Gen Intern Med; 2013 Jun; 28(6):825-9. PubMed ID: 23404201 [TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid-induced osteoporosis preventive care in rheumatology patients. Koller G; Katz S; Charrois TL; Ye C Arch Osteoporos; 2019 Feb; 14(1):16. PubMed ID: 30723883 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D and bisphosphonate therapy in systemic lupus erythematosus patients who receive glucocorticoids: are we offering the best care? Sapkota S; Baig S; Hess T; O'Connell AM; Menk J; Shyne M; Fazeli P; Ensrud K; Shmagel A Lupus; 2020 Mar; 29(3):263-272. PubMed ID: 31996109 [TBL] [Abstract][Full Text] [Related]
4. Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial. Klop C; de Vries F; Vinks T; Kooij MJ; van Staa TP; Bijlsma JW; Egberts AC; Bouvy ML Osteoporos Int; 2014 Jan; 25(1):385-92. PubMed ID: 24221450 [TBL] [Abstract][Full Text] [Related]
5. Prescribed vitamin D and calcium preparations in patients treated with bone remodelling agents in primary care: a report of a pilot study. Bayly JR; Hollands RD; Riordan-Jones SE; Yemm SJ; Brough-Williams I; Thatcher M; Woodman NM; Dixon T Curr Med Res Opin; 2006 Jan; 22(1):131-7. PubMed ID: 16393439 [TBL] [Abstract][Full Text] [Related]
6. MENOPOST--calcium and vitamin D supplementation in postmenopausal osteoporosis treatment: a descriptive cohort study. Reymondier A; Caillet P; Abbas-Chorfa F; Ambrosi V; Jaglal SB; Chapurlat R; Schott AM Osteoporos Int; 2013 Feb; 24(2):559-66. PubMed ID: 22588183 [TBL] [Abstract][Full Text] [Related]
7. Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy. Sadat-Ali M; Alelq AH; Alshafei BA; Al-Turki HA; Abujubara MA Ann Saudi Med; 2009; 29(3):215-8. PubMed ID: 19448373 [TBL] [Abstract][Full Text] [Related]
8. Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis. Nurmi-Lüthje I; Lüthje P; Kaukonen JP; Kataja M; Kuurne S; Naboulsi H; Karjalainen K Drugs Aging; 2009; 26(5):409-21. PubMed ID: 19552493 [TBL] [Abstract][Full Text] [Related]
9. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Buckley L; Guyatt G; Fink HA; Cannon M; Grossman J; Hansen KE; Humphrey MB; Lane NE; Magrey M; Miller M; Morrison L; Rao M; Robinson AB; Saha S; Wolver S; Bannuru RR; Vaysbrot E; Osani M; Turgunbaev M; Miller AS; McAlindon T Arthritis Rheumatol; 2017 Aug; 69(8):1521-1537. PubMed ID: 28585373 [TBL] [Abstract][Full Text] [Related]
10. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis. Ringe JD; Faber H; Fahramand P; Schacht E J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849 [TBL] [Abstract][Full Text] [Related]
11. Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors. Bošković L; Gašparić M; Petković M; Gugić D; Lovasić IB; Soldić Ž; Miše BP; Dabelić N; Vazdar L; Vrdoljak E Breast; 2017 Feb; 31():16-19. PubMed ID: 27810693 [TBL] [Abstract][Full Text] [Related]
12. Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort. McKeown E; Bykerk VP; De Leon F; Bonner A; Thorne C; Hitchon CA; Boire G; Haraoui B; Ferland DS; Keystone EC; Pope JE; Rheumatology (Oxford); 2012 Sep; 51(9):1662-9. PubMed ID: 22539481 [TBL] [Abstract][Full Text] [Related]
13. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Buckley L; Guyatt G; Fink HA; Cannon M; Grossman J; Hansen KE; Humphrey MB; Lane NE; Magrey M; Miller M; Morrison L; Rao M; Byun Robinson A; Saha S; Wolver S; Bannuru RR; Vaysbrot E; Osani M; Turgunbaev M; Miller AS; McAlindon T Arthritis Care Res (Hoboken); 2017 Aug; 69(8):1095-1110. PubMed ID: 28585410 [TBL] [Abstract][Full Text] [Related]
14. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699 [TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. Sambrook PN; Kotowicz M; Nash P; Styles CB; Naganathan V; Henderson-Briffa KN; Eisman JA; Nicholson GC J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733 [TBL] [Abstract][Full Text] [Related]
17. An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis. Caplan L; Hines AE; Williams E; Prochazka AV; Saag KG; Cunningham F; Hutt E Osteoporos Int; 2011 Jan; 22(1):305-15. PubMed ID: 20358362 [TBL] [Abstract][Full Text] [Related]
18. Changing patterns of prescription in vitamin D supplementation in adults: analysis of a regional dataset. Cianferotti L; Parri S; Gronchi G; Rizzuti C; Fossi C; Black DM; Brandi ML Osteoporos Int; 2015 Nov; 26(11):2695-702. PubMed ID: 26068296 [TBL] [Abstract][Full Text] [Related]
19. Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update. Boonen S; Vanderschueren D; Haentjens P; Lips P J Intern Med; 2006 Jun; 259(6):539-52. PubMed ID: 16704554 [TBL] [Abstract][Full Text] [Related]